An experimental drug to treat pancreatic cancer has shown promise in a new study, and researchers say they found a “63% improvement in progression free survival and a safety profile consistent with previous studies” in a 214 patient randomized controlled Phase 2b clinical trial. Pancreatic cancer is, as cancers go, a relatively “bad” cancer to get- [...]
Pancreatic Cancer Trial Drug Shows Promise in Study is a post from: The Inquisitr